Location · LithuaniaUpdated October 10, 2026

Clinical trial software for studies in Lithuania

Lithuanian trials are authorised in parallel by the State Medicines Control Agency and the Bioethics Committee, with Part II documents in Lithuanian and regional committees for other biomedical research. Capture gives Lithuanian teams EU-hosted data capture and consent, free to try.

  • EU hosted in Frankfurt
  • Site-level separation
  • No per-site fee

Free sandbox · No credit card · 21 CFR Part 11 aligned

Study settings · Region
LT

Study region

Lithuania

Competent authority
State Medicines Control Agency (VVKT)
Ethics opinion
Lithuanian Bioethics Committee (LBEK)
Trial regulation
EU CTR via CTIS
Data protection
GDPR, State Data Protection Inspectorate
Hosting region
EU (Frankfurt)
AES-256 at rest TLS in transit Chosen at study setup

Key points for studies in Lithuania

  • Medicinal product trials are submitted through CTIS. The State Medicines Control Agency (VVKT) carries out the scientific assessment and issues the authorisation, and the Lithuanian Bioethics Committee (LBEK) gives the ethics opinion, in parallel.
  • Part II documents must be submitted in Lithuanian.
  • Other biomedical research is assessed by regional biomedical research ethics committees, for example in Vilnius and Kaunas, depending on where the study takes place.
  • The Law on Ethics of Biomedical Research sets the framework for biomedical research and the handling of participants' health information; personal data protection is supervised by the State Data Protection Inspectorate.
  • Capture hosts EU study data in Frankfurt and does not host inside Lithuania.

Regulation

Two bodies, one CTIS application, Lithuanian paperwork

Lithuania applies the EU Clinical Trials Regulation, so a sponsor submits one application in CTIS and does not file separately with local bodies. Under the national Law on Ethics of Biomedical Research the scientific assessment and authorisation sit with VVKT under the Ministry of Health, while the Lithuanian Bioethics Committee provides the ethics conclusion. Both work in parallel, and the authorisation depends on the Agency's assessment and on the ethics opinion. Older sources describe a legal maximum of about 60 days, with approvals commonly taking several weeks in practice; check the agencies' current timelines before you plan site activation.

The language requirement is the practical hurdle. Part II covers the national side of the dossier: the participant information, consent form, recruitment arrangements and site and investigator suitability, and in Lithuania those documents are submitted in Lithuanian. Budget time for translation and for back-translation checks of anything participant-facing, and make sure the version in your data system is the version approved.

Regional committees for other research

Biomedical research outside the CTR, such as observational studies and device studies, is reviewed by regional biomedical research ethics committees, with the competent committee determined by where the study takes place. Confirm the route with the Bioethics Committee. Device investigations follow the EU Medical Device Regulation; see EDC for medical device clinical trials.

Blank eCRF · no subject data

Visit by form matrix

FormSCRD1W2W4W8EOS
DemographicsX
Vital signsXXXXXX
LaboratoryXXX
ECGXX

3. Was the ECG performed?

☐ Yes☐ No

If No, complete question 4.

Protocol CAP-001 · v1.0Page 3 of 24

Build and test a Lithuanian study free

Draft forms from your protocol, add edit checks, and test consent and data entry before anything goes live.

Build your Lithuanian study free

Data protection

GDPR, the Inspectorate and the biomedical research law

Personal data in Lithuanian trials falls under GDPR, applied with the national Law on Legal Protection of Personal Data, and the State Data Protection Inspectorate supervises it. Health information of research participants is also governed by the Law on Ethics of Biomedical Research, so your data protection impact assessment should cover both. Detailed national rules on research exemptions were not confirmed for this guide, so take advice from your data protection officer rather than relying on a general guide.

On the technical side, Capture hosts study data in the EU (Frankfurt) with AES-256 encryption at rest and TLS in transit, separates identities from coded data by role, and keeps an append-only, hash-chained audit trail with timestamp, user, old value, new value and reason for change. See GDPR compliant clinical trial software and, for how a validated use of the system is documented, computer system validation.

Data residency
EU

EU (Frankfurt)

Default for EU-sponsored studies

US

US (N. Virginia)

Default for US-sponsored studies

AES-256 at rest TLS/SSL in transit Chosen at study setup

Lithuanian research

Vilnius, Kaunas and the regional picture

Lithuania's clinical research is concentrated around the university hospitals in Vilnius and Kaunas, and the country is regularly included in multinational trials for its recruitment potential and experienced investigators. Sponsors usually plan it with Latvia and Estonia: one CTIS application, national assessments, sites activated in parallel and one study database with site-level access, so each hospital sees only its own participants and the sponsor sees all countries on one dashboard. The regional overview is in clinical trial software for the Baltics; the neighbours are Latvia and Estonia.

Academic and investigator-initiated teams carry the full sponsor load on a grant. Capture has no setup fee and no per-site fee, a free sandbox with every feature, and charges only when the study goes live, and the AI study builder drafts visits and forms from an uploaded protocol for review. See EDC for investigator-initiated trials.

Before you start

Lithuanian study set-up checklist

CTIS application

One submission for VVKT and the Bioethics Committee, with Part II in Lithuanian.

Route for non-CTR research

Confirm the competent regional biomedical research ethics committee.

Translations approved

Consent, participant information and participant-facing questionnaires, with official translations of validated instruments.

DPIA completed

Covering GDPR and the biomedical research law, with hosting and pseudonymisation described.

Sandbox test run

Run acceptance testing in the free sandbox with sample data before go-live.

Roles and training

Site and sponsor roles set, training recorded for every user.

FAQ

Questions teams ask before they switch

Something not covered here? Ask us directly.

Who authorises clinical trials in Lithuania?

The State Medicines Control Agency (VVKT) carries out the scientific assessment and authorisation, and the Lithuanian Bioethics Committee provides the ethics opinion, both through the CTIS process under the EU Clinical Trials Regulation.

Do documents need to be in Lithuanian?

Part II documents must be submitted in Lithuanian. Capture shows the text you provide; it does not translate for you.

Which committee reviews non-CTR research?

Regional biomedical research ethics committees, such as those in Vilnius and Kaunas, with the competent one depending on where the study takes place. Confirm with the Bioethics Committee.

Who supervises data protection?

The State Data Protection Inspectorate, under GDPR and the national personal data protection law. Participants' health information is also covered by the Law on Ethics of Biomedical Research.

Where is data hosted for Lithuanian studies?

In the EU (Frankfurt), chosen at study setup. Capture does not host inside Lithuania.

Can I run Lithuania with Latvia and Estonia?

Yes. One study can hold sites in all three countries with site-level access and by-site exports.

Can I try it free?

Yes. The free sandbox has every feature with no credit card and no time limit.

Start building your study free

EU-hosted EDC, eCRF and eConsent for Lithuanian studies. Free sandbox, no credit card.

Build your Lithuanian study free